fiona wood

• News

Pharmaxis targeting scar-free recovery from burns with world-first trials

One of the world’s most respected surgeons in the field of burns and trauma recovery will lead world-first clinical trials aiming to stop scars forming, particularly after burn injuries, utilising the latest discovery by biopharmaceuticals company Pharmaxis (ASX: PXS).  The discovery, known as PXS-6302 has shown promising pre‐clinical results in inhibiting the enzymes that play